Next, we compared tumor and normal tissue subgroups, with tumor samples classified as either 1) estrogen (ER) and progesterone (PR) receptor positive tumors or 2) triple-negative tumors (ER-, PR-, Her-2). The gene discussed is PGR; the disease is neoplasm.